Biomerica (BMRA) revenue and earnings history
Biomerica reported revenue of $4.45M for fiscal 2026 (year ended May 31, 2026), −16.2% on the year before, and net income of −$3.77M.
Over 15 years, from fiscal 2011 to fiscal 2026, revenue grew at a compound rate of −0.6% a year.
Revenue and net income, 16 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026ended May 31, 2026 | $4.45M−16.2% | −$5.32M | −$3.77M | −$3.42M | — | — | $476K | — | — | $1.31M | — | 10-K |
| 2025ended May 31, 2025 |
The latest quarter, insider trades and fund moves: Biomerica (BMRA) on OQRO.
Common questions
What was Biomerica's revenue in fiscal 2026?
$4.45M for the year ended May 31, 2026, as reported in its 10-K filed Aug 31, 2026. That is −16.2% on fiscal 2025 ($5.31M).
How fast has Biomerica's revenue grown?
From $4.9M in fiscal 2011 to $4.45M in fiscal 2026: a compound annual growth rate of −0.6% over 15 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Biomerica been profitable?
It reported a net loss in 13 of the years shown (2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025, 2026). The highest net income was $548K in fiscal 2012.
Where these figures come from
The SEC’s companyfacts data: every figure Biomerica tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.